… to improve medication use, the relatively low uptake of pharmacogenetics into clinical
practice provides valuable lessons as to the barriers to implementing “individualized” medicine. …

… clinicians become more familiar with pharmacogenomic research, and what will this field
mean for our clinical practice? … I or phase II of the drug development process, millions of dollars …

… For life-threatening indications such as oncology, many participants felt that there is more
willingness in clinical practice to stratify on the basis of pharmacogenetics and pharma…

… As implementation of pharmacogenetics into routine clinical practice progresses, the use of
computational clinical decision support (CDS) delivered through the electronic health record (…

… Hence, the current schemes of drug development may need to be reconsidered and reshaped
… of pharmacogenomics in medical practice, Daly posits that improved pharmacogenetics …

… role of genomics and genetics in drug response, (b) provide … such as the European Medicines
Agency and the Food and Drug … of biomarkers in clinical practice and in drug development. …

… pharmacogenetics/pharmacogenomics in drug development. The … Case studies & examples
in drug development … for use in drug development, and ultimately in clinical practice, were …

… of the challenges to PGx use in clinical practice, we have … work by our group has described
both the design of a clinical PGx … Our goal is therefore to describe the developed database …

… on clinical research and development and medical practice. In … , and benefits of
pharmacogenetics and pharmacogenomics is … aspects of drug discovery and development. …

… sample within 2 h, which makes pharmacogenetics more attractive to implement in daily
practice … hurdles to overcome to implement pharmacogenetics in clinical practice. However, if all …